Inflammatory cytokines IL-1α, IL-1β, IL-6, and TNF-α impart neuroprotection to an excitotoxin through distinct pathways

Journal of Immunology

Volumn 163, Issue 7, 1999, Pages 3963-3968

  Carlson, Noel G ^a,c   Wieggel, Whitney A ^b   Chen, Jian ^b   Bacchi, Annalisa ^b   Rogers, Scott W ^a,b,c   Gahring, Lorise C ^a,b,c  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF UTAH   (United States)

^c UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; CYTOKINE; EXCITOTOXIN; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 6; N METHYL DEXTRO ASPARTIC ACID; NERVE GROWTH FACTOR; NICOTINE; PROTEIN P55; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR;

ANIMAL CELL; ARTICLE; CALCIUM TRANSPORT; CELL SURVIVAL; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; ISCHEMIA; MOUSE; NERVE CELL NECROSIS; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; STROKE;

ANIMALS; CELLS, CULTURED; CEREBRAL CORTEX; IMMUNE SERA; INFLAMMATION; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; INTERLEUKIN-1; INTERLEUKIN-6; MICE; N-METHYLASPARTATE; NERVE GROWTH FACTORS; NEUROIMMUNOMODULATION; NEURONS; NEUROTOXINS; NICOTINE; NICOTINIC ANTAGONISTS; RECEPTORS, INTERLEUKIN-1; SIALOGLYCOPROTEINS; SIGNAL TRANSDUCTION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0033215124     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (63)

1. Hopkins, S. J., and N. J. Rothwell. 1995. Cytokines and the nervous system. I. Expression and recognition Trends Neurosci. 18:83.
2. Rothwell, N. J., and S. J. Hopkins. 1995. Cytokines and the nervous system II. Actions and mechanisms of action. Trends Neurosci. 18:130.
3. Pan, W., J. E. Zadina, R. E. Harlan, J. T. Weber, W. A. Banks, and A. J. Kastin. 1997. Tumor necrosis factor-α: a neuromodulator in the CNS. Neurosci. Biobehav. Rev. 21:603.
4. Toulmond, S., P. Parnet, and A. C. Linthorst. 1996. When cytokines get on your nerves: cytokine networks and CNS pathologies. Trends Neurosci. 19:409.
5. Maness, L. M., A. J. Kastin, and W. A. Banks. 1998. Relative contributions of a CVO and the microvascular bed to delivery of blood-borne IL-1α to the brain. Am. J. Physiol. 275:E207.
6. Maness, L. M., W. A. Banks, J. E. Zadina, and A. J. Kastin. 1995. Selective transport of blood-borne interleukin-1α into the posterior division of the septum of the mouse brain. Brain Res. 700:83.
7. Gutierrez, E. G., W. A. Banks, and A. J. Kastin. 1993. Murine tumor necrosis factor α is transported from blood to brain in the mouse. J. Neuroimmunol. 47:169.
8. Brosnan, C. F., L. Claudio, F. A. Tansey, and J. Martiney. 1990. Mechanisms of autoimmune neuropathies. Ann. Neurol. 27:S75.
9. Claudio, L., J. A. Martiney, and C. F. Brosnan. 1994. Ultrastructural studies of the blood-retina barrier after exposure to interleukin-1β or tumor necrosis factor-α. Lab Invest. 70:850.
10. Martiney, J. A., J. W. Berman, and C. F. Brosnan. 1992. Chronic inflammatory effects of interleukin-1 on the blood-retina barrier. J. Neuroimmunol. 41:167.
11. Gahring, L. C., N. G. Carlson, R. A. Kulmar, and S. W. Rogers. 1996. Neuronal expression of tumor necrosis factor α in the murine brain. Neuroimmunomodulation 3:289.
12. Tchelingerian, J. L., J. Quinonero, J. Booss, and C. Jacque. 1993. Localization of TNF α and IL-1 α immunoreactivities in striatal neurons after surgical injury to the hippocampus. Neuron 10:213.
13. Schneider, H., F. Pitossi, D. Balschun, A. Wagner, A. del Rey, and H. O. Besedovsky. 1998. A neuromodulatory role of interleukin-1β in the hippocampus. Proc. Natl. Acad. Sci. USA 95:7778.
14. Schobitz, B., D. A. Voorhuis, and E. R. De Kloet. 1992. Localization of interleukin 6 mRNA and interleukin 6 receptor mRNA in rat brain. Neurosci. Lett. 136:189.
15. Miller, L. G., W. R. Galpern, K. Dunlap, C. A. Dinarello, and T. J. Turner. 1991. Interleukin-1 augments γ-aminobutyric acid A receptor function in brain. Mol. Pharmacol. 39:105.
16. Miller, L. G., and J. M. Fahey. 1994. Interleukin-1 modulates GABAergic and glutamatergic function in brain. Ann. NY Acad. Sci. 739:292.
17. Coogan, A., and J. J. O'Connor. 1997. Inhibition of NMDA receptor-mediated synaptic transmission in the rat dentate gyrus in vitro by IL-1β. Neuroreport 8:2107.
18. Bellinger, F. P., S. Madamba, and G. R. Siggins. 1993. Interleukin 1 β inhibits synaptic strength and long-term potentiation in the rat CA1 hippocampus. Brain Res. 628:227.
19. Li, A. J., T. Katafuchi, S. Oda, T. Hori, and Y. Oomura. 1997. Interleukin-6 inhibits long-term potentiation in rat hippocampal slices. Brain Res. 748:30.
20. Bellinger, F. P., S. G. Madamba, I. L. Campbell, and G. R. Siggins. 1995. Reduced long-term potentiation in the dentate gyrus of transgenic mice with cerebral overexpression of interleukin-6. Neurosci. Lett. 198:95.
21. Carlson, N. G., A. Bacchi, S. W. Rogers, and L. C. Gahring. 1998. Nicotine blocks TNF-α-mediated neuroprotection to NMDA by an α-bungarotoxin-sensitive pathway. J. Neurobiol. 35:29.
22. 2+ accumulation. Proc. Natl. Acad. Sci. USA 92: 9328.
23. Bruce, A. J., W. Boling, M. S. Kindy, J. Peschon, P. J. Kraemer, M. K. Carpenter, F. W. Holtsberg, and M. P. Mattson. 1996. Altered neuronal and microglial responses to excitotoxic and ischemic brain injury in mice lacking TNF receptors. Nat. Med. 2:788.
24. Cheng, B., S. Christakos, and M. P. Mattson. 1994. Tumor necrosis factors protect neurons against metabolic-excitotoxic insults and promote maintenance of calcium homeostasis. Neuron 12:139.
25. Whetsell, W. O., Jr. 1996. Current concepts of excitotoxicity. J. Neuropathol. Exp. Neurol. 55:1.
26. Beal, M. F. 1992. Mechanisms of excitotoxicity in neurologic diseases. FASEB J. 6:3338.
27. Choi, D. W. 1994. Calcium and excitotoxic neuronal injury. Ann. NY Acad. Sci. 747:162.
28. Chomczynski, P., and N. Sacchi. 1987. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:156.
29. Dinarello, C. A. 1998. Interleukin-1, interleukin-1 receptors and interleukin-1 receptor antagonist. Int. Rev. Immunol. 16:457.
30. Strijbos, P. J., and N. J. Rothwell. 1995. Interleukin-1β attenuates excitatory amino acid-induced neurodegeneration in vitro: involvement of nerve growth factor. J. Neurosci. 15:3468.
31. Lindstrom, J. 1996. Neuronal nicotinic acetylcholine receptors. Ion Channels 4:377.
32. Sargent, P. B. 1993. The diversity of neuronal nicotinic acetylcholine receptors. Annu. Rev. Neurosci. 16:403.
33. Gruol, D. L., and T. E. Nelson. 1997. Physiological and pathological roles of interleukin-6 in the central nervous system. Mol. Neurobiol. 15:307.
34. Sterneck, E., D. R. Kaplan, and P. F. Johnson. 1996. Interleukin-6 induces expression of peripherin and cooperates with Trk receptor signaling to promote neuronal differentiation in PC12 cells. J. Neurochem. 67:1365.
35. Kossmann, T., V. Hans, H. G. Imhof, O. Trentz, and M. C. Morganti-Kossmann. 1996. Interleukin-6 released in human cerebrospinal fluid following traumatic brain injury may trigger nerve growth factor production in astrocytes. Brain Res. 713:143.
36. Gahring, L. C., H. S. White, S. L. Skradski, N. G. Carlson, and S. W. Rogers. 1997. Interleukin-1α in the brain is induced by audiogenic seizure. Neurobiol. Dis. 3:263.
37. Linthorst, A. C., and J. M. Reul. 1998. Brain neurotransmission during peripheral inflammation. Ann. NY Acad. Sci. 840:139.
38. Lipton, S. A., P. V. Rayudu, Y. B. Choi, N. J. Sucher, and H. S. Chen. 1998. Redox modulation of the NMDA receptor by NO-related species. Prog. Brain Res. 118:73.
39. Bazan, N. G., M. G. Packard, L. Teather, and G. Allan. 1997. Bioactive lipids in excitatory neurotransmission and neuronal plasticity. Neurochem. Int. 30:225.
40. Harkins, A. B., and A. P. Fox. 1998. Activation of nicotinic acetylcholine receptors augments calcium channel-mediated exocytosis in rat pheochromocytoma (PC12) cells. J. Gen. Physiol. 111:257.
41. Tang, K., H. Wu, S. K. Mahata, and D. T. O'Connor. 1998. A crucial role for the mitogen-activated protein kinase pathway in nicotinic cholinergic signaling to secretory protein transcription in pheochromocytoma cells. Mol. Pharmacol. 54: 59.
42. Khiroug, L., E. Sokolova, R. Giniatullin, R. Afzalov, and A. Nistri. 1998. Recovery from desensitization of neuronal nicotinic acetylcholine receptors of rat chromaffin cells is modulated by intracellular calcium through distinct second messengers. J. Neurosci. 18:2458.
43. Warashina, A. 1998. Modulations of early and late secretory processes by activation of protein kinases in the rat adrenal medulla. Biol. Signals Recept. 7:307.
44. Darnay, B. G., and B. B. Aggarwal. 1997. Early events in TNF signaling: a story of associations and dissociations. J. Leukocyte Biol. 61:559.
45. Tracey, K. J., and A. Cerami. 1994. Tumor necrosis factor: a pleiotropic cytokine and therapeutic target. Annu. Rev. Med. 45:491.
46. Wallach, D. 1997. Cell death induction by TNF: a matter of self control. Trends Biochem. Sci. 22:107.
47. Wang, C. Y., M. W. Mayo, and A. S. Baldwin, Jr. 1996. TNF-and cancer therapy-induced apoptosis: potentiation by inhibition of NF-κB. Science 274:784.
48. Ware, C. F., S. VanArsdale, and T. L. VanArsdale. 1996. Apoptosis mediated by the TNF-related cytokine and receptor families. J. Cell. Biochem. 60:47.
49. Schwandner, R., K. Wiegmann, K. Bernardo, D. Kreder, and M. Kronke. 1998. TNF receptor death domain-associated proteins TRADD and FADD signal activation of acid sphingomyelinase. J. Biol. Chem. 273:5916.
50. Singh, I., K. Pahan, M. Khan, and A. K. Singh. 1998. Cytokine-mediated induction of ceramide production is redox-sensitive: implications to proinflammatory cytokine-mediated apoptosis in demyelinating diseases. J. Biol. Chem. 273:20354.
51. Hannun, Y. A. 1996. Functions of ceramide in coordinating cellular responses to stress. Science 274:1855.
52. Mattson, M. P., Y. Goodman, H. Luo, W. Fu, and K. Furukawa. 1997. Activation of NF-κB protects hippocampal neurons against oxidative stress-induced apoptosis: evidence for induction of manganese superoxide dismutase and suppression of peroxynitrite production and protein tyrosine nitration. J. Neurosci. Res. 49: 681.
53. Goodman, Y., and M. P. Mattson. 1996. Ceramide protects hippocampal neurons against excitotoxic and oxidative insults, and amyloid β-peptide toxicity. J. Neurochem. 66:869.
54. Mizushima, N., H. Kohsaka, and N. Miyasaka. 1998. Ceramide, a mediator of interleukin 1, tumour necrosis factor α, as well as Fas receptor signalling, induces apoptosis of rheumatoid arthritis synovial cells. Ann. Rheum. Dis. 57:495.
55. Hofmeister, R., K. Wiegmann, C. Korherr, K. Bernardo, M. Kronke, and W. Falk. 1997. Activation of acid sphingomyelinase by interleukin-1 (IL-1) requires the IL-1 receptor accessory protein. J. Biol. Chem. 272:27730.
56. Carman-Krzan, M., and B. C. Wise. 1993. Arachidonic acid lipoxygenation may mediate interleukin-1 stimulation of nerve growth factor secretion in astroglial cultures. J. Neurosci. Res. 34:225.
57. Hewett, S. J., C. A. Csernansky, and D. W. Choi. 1994. Selective potentiation of NMDA-induced neuronal injury following induction of astrocytic iNOS. Neuron 13:487.
58. Relton, J. K., and N. J. Rothwell. 1992. Interleukin-1 receptor antagonist inhibits ischaemic and excitotoxic neuronal damage in the rat. Brain Res. Bull. 29:243.
59. Yamada, M., and H. Hatanaka. 1994. Interleukin-6 protects cultured rat hippocampal neurons against glutamate-induced cell death. Brain Res. 643:173.
60. Loddick, S. A., A. V. Turnbull, and N. J. Rothwell. 1998. Cerebral interleukin-6 is neuroprotective during permanent focal cerebral ischemia in the rat. J. Cereb. Blood Flow Metab. 18:176.
61. Campbell, I. L. 1998. Structural and functional impact of the transgenic expression of cytokines in the CNS. Ann. NY Acad. Sci. 840:83.
62. Campbell, I. L. 1998. Transgenic mice and cytokine actions in the brain: bridging the gap between structural and functional neuropathology. Brain Res. Rev. 26: 327.
63. Campbell, I. L., A. K. Stalder, Y. Akwa, A. Pagenstecher, and V. C. Asensio. 1998. Transgenic models to study the actions of cytokines in the central nervous system. Neuroimmunomodulation 5:126.